Arrowstreet Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-140,892
Closed -$1.95M 2533
2020
Q2
$1.95M Buy
+140,892
New +$1.91M ﹤0.01% 1494
2020
Q1
Sell
-117,408
Closed -$2.04M 2133
2019
Q4
$2.04M Buy
+117,408
New +$2M ﹤0.01% 1135
2019
Q2
Sell
-10,400
Closed -$182K 1720
2019
Q1
$182K Buy
+10,400
New +$190K ﹤0.01% 1654
2018
Q4
Sell
-69,839
Closed -$988K 1519
2018
Q3
$988K Buy
69,839
+7,600
+12% +$89.1K ﹤0.01% 805
2018
Q2
$604K Buy
+62,239
New +$775K ﹤0.01% 885

Other funds holding VCEL

Arrowstreet Capital's VCEL Position: Q3 2020 in Review

Arrowstreet Capital sold out of Vericel Corp (VCEL) in Q3 2020, closing a stake of 140,892 shares — an estimated $1.95M sold.

Arrowstreet Capital first reported a position in VCEL in Q2 2018 and held it in 5 quarters. The position peaked at $2.04M in Q4 2019. 140 funds tracked by Wall St. Rank hold VCEL as of Q3 2020.

  • Arrowstreet Capital reported no remaining Vericel Corp position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 140,892 Vericel Corp shares in Q3 2020, an estimated $1.95M.
  • Arrowstreet Capital first reported a position in Vericel Corp in Q2 2018 and held it in 5 quarters.
  • Arrowstreet Capital's Vericel Corp position peaked at $2.04M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.